Intra-nasal Ketamine Vs. intravenous morphine in renal colic pain control in emergency patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20121010011067N4

Enrollment

100

Registered

2019-05-18

Start date

2019-05-15

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unspecified renal colic. Unspecified renal colic

Interventions

Intervention 1: Intervention group: One Mg/Kg Ketamine (Rotexmedica pharmaceutical co, Germany) will be administrated intranasaly by a nasal spray. One CC on normal saline will injected intravenously

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: More than 18 year old Patients with acute renal colic pain

Exclusion criteria

Exclusion criteria: Sensitivity to either ketamine or morphine Recent analgesic use before admition

Design outcomes

Primary

Measure	Time frame
Pain control. Timepoint: 0, 15, 30 and 60 minutes after intervention. Method of measurement: Visual analog scale for pain.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahboub Pouraghaei

Tabriz University of Medical Sciences

pouraghaeim@tbzmed.ac.ir+98 41 3335 2078

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026